Reply to Carlos G. Wambier and Gerard J. Nau’s Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285–93. Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients: Still No Positive Effect of Enzalutamide for Hospitalized COVID-19 Patients

Detalles Bibliográficos
Autores principales: Welén, Karin, Rosendal, Ebba, Freyhult, Eva, Oh, William K., Gisslén, Magnus, Ahlm, Clas, Connolly, Anne-Marie Fors, Överby, Anna K., Josefsson, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association of Urology. Published by Elsevier B.V. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864103/
https://www.ncbi.nlm.nih.gov/pubmed/35248411
http://dx.doi.org/10.1016/j.eururo.2022.02.016

Ejemplares similares

Ejemplares similares